Valuation for Lytix Biopharma AS (id:10507 LYTIX)
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|---|---|---|
| Trailing P/E | -2.67 |
|
|
| Forward P/E | -1.60 |
|
|
| Price to sales | 25.76 |
|
|
| Price to book | 5.85 |
|
|
| Enterprise to revenue | 16.10 |
|
|
| Enterprise to ebitda | -2.97 |
|
|